Phase I/II trial of YHI-1003 plus Capecitabine
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/100604
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: investigational material(s)
Generic name etc : YHI-1003
INN of investigational material : Perifosine
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material : oral
Primary outcome(s): safety
CTCAE v4.0
Study Design: open-label, multicenter trial
创建时间：
2011-12-15
